Leader Of US FDA's EU Mutual Recognition Effort Departs For Industry
Dara Corrigan will become Fresenius-Kabi’s VP for global affairs and policy.
You may also be interested in...
Leveraging foreign surveillance inspections could help FDA ensure more sites are inspected more often.
Office of New Drug's chief of staff will become Amgen's director of global regulatory policy and R&D.
Uhl, who shepherded OGD into the user fee era, will retire in February.